DIABETIC PERIPHERAL NEUROPATHY
Clinical trials for DIABETIC PERIPHERAL NEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new DIABETIC PERIPHERAL NEUROPATHY trials appear
Sign up with your email to follow new studies for DIABETIC PERIPHERAL NEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug duo soothe nerve pain? new trial underway
Symptom relief OngoingThis study tests a new medicine called CagriSema (a combination of two drugs) to see if it can reduce painful nerve damage in people with type 2 diabetes. About 142 adults with diabetes and nerve pain will receive either CagriSema or a placebo for around 10 months. The main goal …
Matched conditions: DIABETIC PERIPHERAL NEUROPATHY
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Symptom relief
Last updated May 07, 2026 18:40 UTC
-
New study links blood sugar to nerve damage in diabetics
Knowledge-focused ENROLLING_BY_INVITATIONThis study is observing 50 adults aged 45-76 with diabetic peripheral neuropathy to see how well their blood sugar is controlled and how it relates to nerve signal speed in the leg. Researchers will use standard tests like nerve conduction studies and foot exams. The goal is to f…
Matched conditions: DIABETIC PERIPHERAL NEUROPATHY
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated May 17, 2026 03:27 UTC